Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immuneering Corporation

    NASDAQ: IMRX · Real-Time Price · USD
    3.52
    0.33 (10.34%)
    At close: Jun 27, 2025, 3:59 PM
    3.49
    -0.99%
    After-hours: Jun 27, 2025, 05:57 PM EDT

    Immuneering Statistics

    Share Statistics

    Immuneering has 35.99M shares outstanding. The number of shares has increased by 21.02% in one year.

    Shares Outstanding

    n/a
    		 35.99M

    Shares Change (YoY)

    n/a
    		 21.02%

    Shares Change (QoQ)

    n/a
    		 15.58%

    Owned by Institutions (%)

    n/a
    		 14.42%

    Shares Floating

    n/a
    		 25.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 867

    FTD / Avg. Volume

    n/a
    		 0.09%

    Short Selling Information

    The latest short interest is 924.55K, so 2.57% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 924.55K

    Short % of Shares Out

    n/a
    		 2.57%

    Short % of Float

    n/a
    		 3.36%

    Short Ratio (days to cover)

    n/a
    		 3.64

    Valuation Ratios

    The PE ratio is -1.08 and the forward PE ratio is -1.93. Immuneering's PEG ratio is -0.13.

    PE Ratio

    n/a
    		 -1.08

    Forward PE

    n/a
    		 -1.93

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 1.59

    P/FCF Ratio

    n/a
    		 -1.2

    PEG Ratio

    n/a
    		 -0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immuneering.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 5.28

    Quick Ratio

    n/a
    		 5.28

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,130,314.81

    Employee Count

    n/a
    		 54

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 122.38% in the last 52 weeks. The beta is 0, so Immuneering's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 122.38%

    50-Day Moving Average

    n/a
    		 1.71

    200-Day Moving Average

    n/a
    		 1.89

    Relative Strength Index (RSI)

    n/a
    		 69.66

    Average Volume (20 Days)

    n/a
    		 975,595

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -64.07M

    Net Income

    n/a
    		 -61.04M

    EBITDA

    n/a
    		 -63.69M

    EBIT

    n/a
    		 -64.07M

    Earnings Per Share (EPS)

    n/a
    		 -2.04
    Full Income Statement

    Balance Sheet

    The company has 36.15M in cash and 4.16M in debt, giving a net cash position of 31.98M.

    Cash & Cash Equivalents

    n/a
    		 36.15M

    Total Debt

    n/a
    		 4.16M

    Net Cash

    n/a
    		 31.98M

    Retained Earnings

    n/a
    		 -224.29M

    Total Assets

    n/a
    		 50.68M

    Working Capital

    n/a
    		 33.1M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -55M and capital expenditures -84.88K, giving a free cash flow of -55.08M.

    Operating Cash Flow

    n/a
    		 -55M

    Capital Expenditures

    n/a
    		 -84.88K

    Free Cash Flow

    n/a
    		 -55.08M

    FCF Per Share

    n/a
    		 -1.84
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IMRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMRX is $11.5, which is 261.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $11.5

    Price Target Difference

    n/a
    		 261.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.78

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist